The effect of coagulation factors in 2019 novel coronavirus patients: A systematic review and meta-analysis

Guiling Xiang1, Shengyu Hao, Cuiping Fu

  • 1Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital Fudan University, Shanghai, China.

Medicine
|February 20, 2021
PubMed

Insights

Coagulation dysfunction is linked to severe COVID-19 and higher mortality. Monitoring coagulation markers like D-dimer is crucial for managing severe cases and preventing complications.

Area of Science:

  • Hematology
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • The association between coagulation dysfunction and severe Coronavirus Disease 2019 (COVID-19) remains unclear.
  • Existing studies present inconsistent findings regarding the role of coagulopathy in COVID-19 patients.

Purpose of the Study:

  • To investigate the impact of coagulation dysfunction on COVID-19 severity.
  • To explore the relationship between coagulopathy and mortality in COVID-19 patients.

Main Methods:

  • A systematic literature search was conducted across PubMed, Cochrane, and Embase databases (December 2019 - April 2020).
  • Meta-analysis of observational studies following MOOSE guidelines was performed.
  • Data on coagulation parameters (Platelets, PT, APTT, fibrin, D-dimer), dysfunction prevalence, and mortality were extracted and analyzed using meta-regression.

Main Results:

  • Sixteen studies with 2,139 COVID-19 patients were included.
  • Severe COVID-19 cases showed significantly higher D-dimer, PT, and fibrin levels, and more frequent coagulation dysfunction.
  • Coagulopathy was associated with a substantially higher mortality risk (RR 10.86) and increased prevalence of Acute Respiratory Distress Syndrome (ARDS).

Conclusions:

  • Coagulation dysfunction is associated with increased COVID-19 severity and mortality.
  • Elevated PT, fibrin, and D-dimer levels may indicate disease progression and are linked to non-survival.
  • Effective monitoring of coagulation function is essential for managing severe COVID-19 and preventing related coagulopathy, despite evidence quality limitations.
Abstract

Related Concept Videos

Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
13.0K
Coagulation01:09

Coagulation

The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
8.7K
Coagulation01:06

Coagulation

Colloidal solids are solid particles suspended in solution. They are usually negatively charged, attracting a compact primary layer of positively charged ions, which attract more counterions to form an electrical double layer. Electrostatic repulsion between the charged double layers prevents the particles from colliding, stabilizing the colloids. These solids are often undesirable because they can contain toxins that are difficult to remove. Coagulation is a technique that helps aggregate and...
619
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
109
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
121
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.2K